Raymond James Financial Services Advisors, Inc. Gilead Sciences, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 252,749 shares of GILD stock, worth $27.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

252,749

Previous 267,723 5.59%

Holding current value

$27.8 Million

Previous $18.4 Million 15.34%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$66.59 - $83.99 $997,118 - $1.26 Million	-14,974 Reduced 5.59%	252,749 $21.2 Million
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $4.08 Million - $4.71 Million	-64,635 Reduced 19.45%	267,723 $18.4 Million
Q1 2024 Apr 22, 2024	BUY	$71.58 - $87.29 $2.58 Million - $3.15 Million	36,037 Added 12.16%	332,358 $24.3 Million
Q4 2023 Jan 16, 2024	BUY	$73.27 - $83.09 $3.32 Million - $3.76 Million	45,272 Added 18.03%	296,321 $24 Million
Q3 2023 Oct 24, 2023	SELL	$73.94 - $80.67 $1.36 Million - $1.49 Million	-18,436 Reduced 6.84%	251,049 $18.8 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $1.91 Million - $2.18 Million	-25,114 Reduced 8.52%	269,485 $20.8 Million
Q1 2023 Apr 14, 2023	BUY	$77.31 - $88.08 $3.68 Million - $4.2 Million	47,644 Added 19.29%	294,599 $24.4 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $1.55 Million - $2.23 Million	-24,948 Reduced 9.18%	246,955 $21.2 Million
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $471,378 - $538,435	7,917 Added 3.0%	271,903 $16.8 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $1.7 Million - $1.91 Million	-29,424 Reduced 10.03%	263,986 $16.3 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $2.54 Million - $3.18 Million	43,788 Added 17.54%	293,410 $17.4 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $2.85 Million - $3.24 Million	-43,946 Reduced 14.97%	249,622 $18.1 Million
Q3 2021 Nov 02, 2021	SELL	$67.69 - $73.03 $1.41 Million - $1.52 Million	-20,760 Reduced 6.6%	293,568 $20.5 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $2.01 Million - $2.2 Million	31,699 Added 11.22%	314,328 $21.6 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $261,300 - $298,143	-4,355 Reduced 1.52%	282,629 $18.3 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2.29 Million - $2.6 Million	-40,353 Reduced 12.33%	286,984 $16.7 Million
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $5.09 Million - $6.4 Million	-81,981 Reduced 20.03%	327,337 $20.7 Million
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $4.13 Million - $4.8 Million	-57,118 Reduced 12.25%	409,318 $31.5 Million
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $7.59 Million - $9.72 Million	121,117 Added 35.07%	466,436 $34.9 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $2 Million - $2.2 Million	32,405 Added 10.36%	345,319 $22.4 Million
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $3.93 Million - $4.34 Million	62,845 Added 25.13%	312,914 $19.8 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $633,858 - $710,798	-10,245 Reduced 3.94%	250,069 $16.9 Million
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $284,011 - $318,167	-4,542 Reduced 1.71%	260,314 $16.9 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $103,583 - $135,169	1,711 Added 0.65%	264,856 $16.6 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $2.86 Million - $3.16 Million	40,087 Added 17.97%	263,145 $20.3 Million
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $5.18 Million - $6.04 Million	-79,816 Reduced 26.35%	223,058 $15.8 Million
Q1 2018 Apr 16, 2018	BUY	$72.84 - $88.8 $1.13 Million - $1.37 Million	15,459 Added 5.38%	302,874 $22.8 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $286,165 - $335,917	4,022 Added 1.42%	287,415 $20.6 Million
Q3 2017 Oct 26, 2017	SELL	$72.11 - $85.47 $356,367 - $422,392	-4,942 Reduced 1.71%	283,393 $23 Million
Q2 2017 Aug 15, 2017	BUY	N/A	288,335	288,335 $20.4 Million

Others Institutions Holding GILD

# of Institutions

2,286

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Gilead Sciences, Inc. Transaction History